This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Medicinal Bioconvergence Research Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Byung Woo Han: Innovator in Chemokine Research
Introduction
Byung Woo Han is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biochemistry, particularly in the area of chemokine activity. His work has implications for various medical applications, showcasing the importance of innovative research in the life sciences.
Latest Patents
Byung Woo Han holds a patent for a polypeptide having chemokine activity. This invention is mediated by binding to C-C chemokine receptor type 3 (CCR3) and comprises SEQ ID NO: 1. The patent outlines the uses of this polypeptide, which could lead to advancements in therapeutic strategies.
Career Highlights
He is currently affiliated with the Medicinal Bioconvergence Research Center, where he continues to explore the potential of his research. His work is characterized by a commitment to understanding complex biological processes and developing innovative solutions.
Collaborations
Byung Woo Han collaborates with notable colleagues, including Sunghoon Kim and Min Chul Park. These partnerships enhance the research environment and foster the exchange of ideas, which is crucial for scientific advancement.
Conclusion
Byung Woo Han's contributions to chemokine research exemplify the impact of innovative thinking in the field of biochemistry. His patent and ongoing work at the Medicinal Bioconvergence Research Center highlight the importance of collaboration and dedication in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile